FDA Approves Bristol Myers Squibb's Camzyos As First Treatment For Children With Obstructive Hypertrophic Cardiomyopathy Weighing At Least 30 kg

Benzinga Newsdesk www.benzinga.com Neutral 84.9%

Neg 0% Neu 84.9% Pos 0%

https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-drug-improve-functional-capacity-and-symptoms-children-rare-inherited-heart